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From the Archive
W
hen Caroline Damsky moved 
her lab to the University of 
California, San Francisco, 
in 1985, she knew she would have an 
instant colleague in Zena Werb. There 
was a natural connection between their 
work. That connection would be reﬂ  ected 
in their discoveries, which delineated 
an integrin-mediated pathway from 
the extracellular matrix (ECM) outside 
the cell to the internal, gene-expressing 
life of the cell.
Werb and Damsky’s interests—
  metalloproteinase (MMP) gene expres-
sion and adhesion receptor antibod-
ies—were both correlated with changes 
in cell shape and the actin cytoskeleton. 
Some dismissed the shape changes as 
simple, physical responses to a  changing 
attachment environment, with no need to 
invoke signaling, but the two wondered 
if there was something more. “Were the 
cells getting signals from the ECM that 
could affect [protease] gene expres-
sion?” asks Damsky. “Zena was the doy-
enne of the protease side of things and 
I was the doyenne of the integrin side.”
Until this point, integrins had been 
viewed as being important primarily in 
“sticking cells down,” says Damsky. Her 
hunch was that integrin’s role went be-
yond glue to sending signals of some 
kind. At the same time, work paralleling 
Werb’s suggested that proteases had 
some part in regulating cell connections 
to the ECM. Damsky says it was only 
natural to combine forces.
When Damsky added her adhe-
sion-blocking antibodies to ﬁ  broblasts 
in culture, thus speciﬁ  cally neutralizing 
a ﬁ   bronectin receptor named α5β1 
integrin, the cells started expressing 
collagenase and stromelysin, two ECM-
degrading MMPs (Werb et al., 1989). 
Receptor clustering was needed: induc-
tion was increased when the antibodies 
were cross-linked and it did not occur 
with monovalent fragments.
Although native ﬁ  bronectin did not 
induce protease expression, the authors 
showed that fragments of ﬁ  bronectin, 
ranging from 120 kD to six amino ac-
ids, did. The fragments shared the RGD 
cell binding sequence characterized by 
Pytela et al. (1985). This suggested that 
degradation products of ﬁ  bronectin, 
bound to integrins, could turn on prote-
ase expression.
“Cells were recognizing differ-
ent states of the matrix molecule,” says 
Werb. “Embedded in a molecule was 
both the mechanism for homeostasis as 
well as for cell migration and changes 
that might occur, for example, in wound 
healing.” The idea ﬁ  t  with  emerging 
studies showing distinct responses to 
different ﬁ   bronectin fragments. For ex-
ample, human monocytes had chemo-
tactic activity to the cell-binding domain 
of ﬁ  bronectin, but not to the intact mol-
ecule (Clark et al., 1988).
Damsky notes wryly that although 
they were ﬁ   rst to demonstrate integrin 
signaling, integrins became “respect-
able” signaling molecules after the 
labs of Joan Brugge, Thomas Parsons, 
and Lewis Romer showed that integrin 
ligation triggered the phosphorylation 
of focal adhesion kinase (Lipfert et al., 
1992; Burridge et al., 1992). Neverthe-
less, the Werb/Damsky collaboration 
clearly set up a very large ﬁ  eld,  says 
Werb. She notes with pride that their 
work appears at the top of the list of 
3,488 papers pulled up by a search for 
“integrin signaling.” KP
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Cells with a ligated ﬁ  bronectin receptor (top) express collagenase (bottom).
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